| 國家衛生研究院 |
2011-09 |
Phase II study of low-dose everolimus plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for first-line treatment of metastatic or recurrent gastric cancers
|
Yeh, K;Shen, YC;Li, CP;Yen, CJ;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Cheng, AL |
| 國立成功大學 |
2011-09-23 |
Phase II Study of Low-dose Everolimus Plus Weekly Cisplatin and 24-hour Infusion of High-dose 5-fluorouracil and Leucovorin for First-line Treatment of Metastatic or Recurrent Gastric Cancers
|
Yeh, K. |
| 臺大學術典藏 |
2020-03-31T03:59:14Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Hsu C.-H.; Tzen K.-Y.; Cheng A.-L.; Yeh K.-H.; Hsu F.-M.; Huang P.-M.; JANG-MING LEE; Wang H.-P.; Chia-Hsien Cheng J.; Wu Y.-C.; Lin C.-C.; Huang T.-C.; Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Jang-Ming Lee;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Yeh K.-H.;Cheng A.-L.;Tzen K.-Y.;Hsu C.-H. |
| 臺大學術典藏 |
2019 |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Hsu C.-H.; Cheng A.-L.; Tzen K.-Y.; Yeh K.-H.; Hsu F.-M.; Huang P.-M.; Wang H.-P.; Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng;Lee J.-M.;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Yeh K.-H.;Cheng A.-L.;Tzen K.-Y.;Hsu C.-H.; Huang T.-C.; Lin C.-C.; Wu Y.-C.; CHIA-HSIEN CHENG; Lee J.-M. |
| 臺大學術典藏 |
2019 |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Hsu C.-H.; Tzen K.-Y.; Cheng A.-L.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; PEI-MING HUANG; Hsu F.-M.; Yeh K.-H.; Lin C.-C.; Huang T.-C.; Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Lee J.-M.;Wang H.-P.;Pei-Ming Huang;Hsu F.-M.;Yeh K.-H.;Cheng A.-L.;Tzen K.-Y.;Hsu C.-H. |
| 臺大學術典藏 |
2019 |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Tzen K.-Y; Hsu C.-H.; Huang P.-M; Feng-Ming Hsu; Yeh K.-H; Cheng A.-L; Lee J.-M; Wang H.-P; Chia-Hsien Cheng J; Wu Y.-C; Lin C.-C; Huang T.-C; Huang T.-C;Lin C.-C;Wu Y.-C;Chia-Hsien Cheng J;Lee J.-M;Wang H.-P;Huang P.-M;Feng-Ming Hsu;Yeh K.-H;Cheng A.-L;Tzen K.-Y;Hsu C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:05Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Huang T.-C; Chia-Chi Lin; Wu Y.-C; Chia-Hsien Cheng J; Lee J.-M; Wang H.-P; Huang P.-M; Hsu F.-M; Yeh K.-H; Cheng A.-L; Tzen K.-Y; Hsu C.-H.; Hsu C.-H.;Tzen K.-Y;Cheng A.-L;Yeh K.-H;Hsu F.-M;Huang P.-M;Wang H.-P;Lee J.-M;Chia-Hsien Cheng J;Wu Y.-C;Chia-Chi Lin;Huang T.-C |
| 臺大學術典藏 |
2020-04-28T07:25:11Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; Yeh K.-H.; Cheng A.-L.; Tzen K.-Y.; CHIH-HUNG HSU; Lin C.-C.; Wu Y.-C.; Huang T.-C.; Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Lee J.-M.;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Yeh K.-H.;Cheng A.-L.;Tzen K.-Y.;Chih-Hung Hsu |
| 臺大學術典藏 |
2021-01-15T03:46:26Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Huang T.-C.; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; HSIU-PO WANG; Huang P.-M.; Hsu F.-M.; Yeh K.-H.; Cheng A.-L.; Tzen K.-Y.; Hsu C.-H. |
| 臺大學術典藏 |
2021-03-18T05:58:55Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Huang T.-C.; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; Yeh K.-H.; Cheng A.-L.; KAI-YUAN TZEN; Hsu C.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:24Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Huang T.-C.; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; Yeh K.-H.; ANN-LII CHENG; Tzen K.-Y.; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:17Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Lee J.-M.;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Kun-Huei Yeh;Cheng A.-L.;Tzen K.-Y.;Hsu C.-H.; Huang T.-C.; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; KUN-HUEI YEH; Cheng A.-L.; Tzen K.-Y.; Hsu C.-H. |
| 臺大學術典藏 |
2021-03-10T05:34:17Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Ta-Chen Huang; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; Yeh K.-H.; Cheng A.-L.; Tzen K.-Y.; Hsu C.-H. |
| 國立臺灣大學 |
2008 |
Phase Ii Study of Sorafenib Plus Tegafur/Uracil (Uft) in Patients with Advanced Hepatocellular Carcinoma (Hcc)
|
沈盈君; 邵幼雲; 徐志宏; 許駿; 林宗哲; 陳培哲; 丁雅慧; 鄭安理; SHEN, YING-CHUN; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; LIN, ZONG-ZHE; CHEN, PEI-JER; DING, YEA-HUI; CHENG, ANN-LII |
| 國家衛生研究院 |
2000-08 |
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy
|
Chen, YM; Perng, RP; Yang, KY; Lin, WC; Wu, HW; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2011-02 |
Phase II study of weekly low-dose everolimus plus weekly 24-hour infusions of cisplatin and high-dose 5-fluorouracil and leucovorin for first-line treatment in patients with advanced gastric cancers
|
Yeh, K;Shen, Y;Li, C;Yen, C;Hsu, C;Lin, Z;Chen, L;Su, W;Chao, Y;Cheng, A |
| 國立臺灣大學 |
2004 |
Phase Ii Study of Weekly Oxaliplatin and 24-H Infusion of High-Dose 5- Fluorouracil and Folinic Acid in the Treatment of Advanced Gastric Cancer
|
趙毅; 葉坤輝; 張啟仁; 陳立宗; 趙祖怡; 張正雄; 張俊彥; 鍾智淵; 高偉堯; 謝瑞坤; 鄭安理; CHAO, YEE; YEH, KUN-HUEI; CHANG, CHEE-JEN; CHEN, LI-TZONG; CHAO, TSU-YI; CHANG, CHENG-SHYONG; CHANG, JANG-YANG; CHUNG, CHIH-YUAN; KAO, WOEI-YAU; HSIEH, RUEY-KUN; CHENG, ANN-LII |
| 國家衛生研究院 |
2004-08-02 |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer
|
Chao, Y; Yeh, KH; Chang, CJ; Chen, LT; Chao, TY; Wu, MF; Chang, CS; Chang, JY; Chung, CY; Kao, WY; Hsieh, RK; Cheng, AL |
| 臺大學術典藏 |
2018-09-10T04:46:19Z |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer
|
Chao, Y.;Yeh, K.H.;Chang, C.J.;Chen, L.T.;Chao, T.Y.;Wu, M.F.;Chang, C.S.;Chang, J.Y.;Chung, C.Y.;Kao, W.Y.;Hsieh, R.K.;Cheng, A.L.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:19Z |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer
|
Chao Y.; Yeh K.H.; Chang C.J.; Chen L.T.; Chao T.Y.; Wu M.F.; Chang C.S.; Chang J.Y.; Chung C.Y.; Kao W.Y.; Hsieh R.K.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-01-28T01:06:50Z |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer
|
Chao Y.;Kun-Huei Yeh;Chang C.J.;Chen L.T.;Chao T.Y.;Wu M.F.;Chang C.S.;Chang J.Y.;Chung C.Y.;Kao W.Y.;Hsieh R.K.;Cheng A.L.; Chao Y.; KUN-HUEI YEH; Chang C.J.; Chen L.T.; Chao T.Y.; Wu M.F.; Chang C.S.; Chang J.Y.; Chung C.Y.; Kao W.Y.; Hsieh R.K.; Cheng A.L. |
| 高雄醫學大學 |
2004 |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer.
|
趙毅;陳立宗;張俊彥; Chao Y;Yeh KH;Chang CJ;Chen LT;Chao TY;Wu MF;Chang CS;Chang JY;Chung CY;Kao WY;Hsieh RK;Cheng AL. |
| 國立臺灣大學 |
2004-08 |
Phase II study of weekly oxaliplatin and 24-hour infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer.
|
Chao Y; Kun-Huei Yeh; Chang CJ; Chen LT; Chao TY; Wu MF; Chang CS; Chang JY; Chung CY; Kao WY; Hsieh RK; Cheng AL |
| 國立臺灣大學 |
2005 |
Phase Ii Study of Weekly Paclitaxel and 24-Hour Infusion of High-Dose 5- Fluorouracil and Leucovorin in the Treatment of Recurrent or Metastatic Gastric Cancer
|
葉坤輝; 盧彥伸; 徐志宏; 林靜芳; 許駿; 郭頌鑫; 鄭安理; YEH, KUN-HUEI; LU, YEN-SHEN; HSU, CHIH-HUNG; LIN, JING-FANG; HSU, CHIUN; KUO, SUNG-HSIN; CHENG, ANN-LII |
| 臺大學術典藏 |
2020-04-28T07:25:35Z |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
|
Yeh K.-H.;Lu Y.-S.;Chih-Hung Hsu;Lin J.-F.;Hsu C.;Kuo S.-H.;Li Jr. S.;Cheng A.-L.; Yeh K.-H.; Lu Y.-S.; CHIH-HUNG HSU; Lin J.-F.; Hsu C.; Kuo S.-H.; Li Jr. S.; Cheng A.-L. |
